William S Dalton

William S Dalton

UNVERIFIED PROFILE

Are you William S Dalton?   Register this Author

Register author
William S Dalton

William S Dalton

Publications by authors named "William S Dalton"

Are you William S Dalton?   Register this Author

73Publications

1076Reads

24Profile Views

BCL2 Amplicon Loss and Transcriptional Remodeling Drives ABT-199 Resistance in B Cell Lymphoma Models.

Cancer Cell 2019 May;35(5):752-766.e9

Chemical Biology and Molecular Medicine Program, Moffitt Cancer Center & Research Institute, Tampa, FL 33612, USA; Department of Laboratory Medicine and Hematopathology, Moffitt Cancer Center & Research Institute, Tampa, FL 33612, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ccell.2019.04.005DOI Listing
May 2019

Optimizing Cancer Treatment Using Game Theory: A Review.

JAMA Oncol 2019 Jan;5(1):96-103

Cancer Biology and Evolution Program, Moffitt Cancer Center, Tampa, Florida.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamaoncol.2018.3395DOI Listing
January 2019

Patient Enrichment for Precision-Based Cancer Clinical Trials: Using Prospective Cohort Surveillance as an Approach to Improve Clinical Trials.

Clin Pharmacol Ther 2018 07 23;104(1):23-26. Epub 2018 Mar 23.

Ohio State University Comprehensive Cancer Center; The James Cancer Hospital and Solove Research Institute, Ohio State University, Columbus, Ohio, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cpt.1051DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6032821PMC
July 2018

A genome-based model for adjusting radiotherapy dose (GARD): a retrospective, cohort-based study.

Lancet Oncol 2017 02 18;18(2):202-211. Epub 2016 Dec 18.

Department of Radiation Oncology, Moffitt Cancer Center and Research Institute, Tampa, FL, USA; Department of Chemical Biology and Molecular Medicine, Moffitt Cancer Center and Research Institute, Tampa, FL, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1470-2045(16)30648-9DOI Listing
February 2017

Treatment of acquired drug resistance in multiple myeloma by combination therapy with XPO1 and topoisomerase II inhibitors.

J Hematol Oncol 2016 08 24;9(1):73. Epub 2016 Aug 24.

Chemical Biology and Molecular Medicine Program, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s13045-016-0304-zDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4997728PMC
August 2016

Collaborative biomedicine in the age of big data: the case of cancer.

J Med Internet Res 2014 Apr 7;16(4):e101. Epub 2014 Apr 7.

PricewaterhouseCoopers LLP, McLean, VA, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2196/jmir.2496DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4004150PMC
April 2014

Turning the tide against cancer through sustained medical innovation: the pathway to progress.

Clin Cancer Res 2014 Mar 12;20(5):1081-6. Epub 2014 Feb 12.

Authors' Affiliations: Center for Learning Healthcare, Duke Cancer Center Research Program, Division of Medical Oncology, Department of Medicine, Duke University School of Medicine, Durham, North Carolina; Personalized Medicine Coalition; and Pharmaceutical Research and Manufacturers of America, Washington, DC; Complex Adaptive Systems Initiative, School of Life Sciences, Arizona State University, Tucson, Arizona; M2Gen, DeBartolo Family Personalized Medicine Institute, Moffitt Cancer Center, Tampa, Florida; American Association for Cancer Research, Philadelphia, Pennsylvania; Opus Three LLC, Rockville, Maryland; Clinical Development and Medical Affairs, Eli Lilly and Company, Indianapolis, Indiana; Feinstein Kean Healthcare, Cambridge, Massachusetts; Global Strategic Market Access and Policy, Celgene Corporation, Summit, New Jersey; American Cancer Society, Atlanta, Georgia; The Khalifa Institute for Personalized Cancer Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas; and Breast Oncology Program, Applied Genomics, University of California, San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, California.

View Article

Download full-text PDF

Source
http://clincancerres.aacrjournals.org/lookup/doi/10.1158/107
Publisher Site
http://dx.doi.org/10.1158/1078-0432.CCR-13-3430DOI Listing
March 2014

Sequence of novel agents in multiple myeloma: an instrumental variable analysis.

Leuk Res 2013 Sep 25;37(9):1077-82. Epub 2013 Jun 25.

Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.leukres.2013.06.005DOI Listing
September 2013

The creation of an integrated health-information platform: building the framework to support personalized medicine.

Per Med 2012 Aug;9(6):621-632

H Lee Moffitt Cancer Center & Research Institute, 12902 Magnolia Drive, Tampa, FL 33612, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/pme.12.76DOI Listing
August 2012

Implementing personalized medicine in a cancer center.

Cancer J 2011 Nov-Dec;17(6):528-36

Department of Biomedical Informatics, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL, USA.

View Article

Download full-text PDF

Source
http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:land
Publisher Site
http://dx.doi.org/10.1097/PPO.0b013e318238216eDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3240816PMC
June 2012

Monitoring a nuclear factor-κB signature of drug resistance in multiple myeloma.

Mol Cell Proteomics 2011 Nov 16;10(11):M110.005520. Epub 2011 Aug 16.

Molecular Oncology, H. Lee Moffitt Cancer Center and Research Institute University of South Florida, Tampa, FL 33612, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1074/mcp.M110.005520DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3226396PMC
November 2011

Follicular dendritic cell-dependent drug resistance of non-Hodgkin lymphoma involves cell adhesion-mediated Bim down-regulation through induction of microRNA-181a.

Blood 2010 Dec 14;116(24):5228-36. Epub 2010 Sep 14.

Department of Malignant Hematology, Molecular Oncology and Experimental Therapeutics Program, H. Lee Moffitt Cancer Center and Research Institute at the University of South Florida, Tampa, FL, USA.

View Article

Download full-text PDF

Source
http://www.bloodjournal.org/cgi/doi/10.1182/blood-2010-03-27
Publisher Site
http://dx.doi.org/10.1182/blood-2010-03-275925DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3012540PMC
December 2010

The 2010 Health Care Reform Act: a potential opportunity to advance cancer research by taking cancer personally.

Clin Cancer Res 2010 Dec;16(24):5987-96

H Lee Moffitt Cancer Center and Research Institute, Tampa, Florida 33612, USA.

View Article

Download full-text PDF

Source
http://clincancerres.aacrjournals.org/cgi/doi/10.1158/1078-0
Publisher Site
http://dx.doi.org/10.1158/1078-0432.CCR-10-1216DOI Listing
December 2010

A novel TNF receptor-associated factor 6 binding domain mediates NF-kappa B signaling by the common cytokine receptor beta subunit.

J Immunol 2010 Aug 9;185(3):1606-15. Epub 2010 Jul 9.

Department of Experimental Therapeutics and Oncologic Sciences, H. Lee Moffitt Cancer Center and Research Institute, University of South Florida, Tampa, FL 33612, USA.

View Article

Download full-text PDF

Source
http://www.jimmunol.org/content/185/3/1606.full.pdf
Web Search
http://www.jimmunol.org/cgi/doi/10.4049/jimmunol.0902026
Publisher Site
http://dx.doi.org/10.4049/jimmunol.0902026DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3050047PMC
August 2010

Environmental-mediated drug resistance: a target for multiple myeloma therapy.

Expert Rev Hematol 2009 Dec;2(6):649-62

Departments of Experimental Therapeutics and Oncologic Sciences, H. Lee Moffitt Cancer Center and Research Institute, University of South Florida, 12902 Magnolia Drive, Tampa, FL 33612, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1586/ehm.09.55DOI Listing
December 2009

Environment-mediated drug resistance: a major contributor to minimal residual disease.

Nat Rev Cancer 2009 Sep 20;9(9):665-74. Epub 2009 Aug 20.

Department of Experimental Therapeutics and Oncologic Sciences, H. Lee Moffitt Cancer Center, Florida 33612, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nrc2714DOI Listing
September 2009

Kinome siRNA screen identifies SMG-1 as a negative regulator of hypoxia-inducible factor-1alpha in hypoxia.

J Biol Chem 2009 Jun 30;284(25):16752-8. Epub 2009 Apr 30.

Department of Immunology and Microbial Science, The Scripps Research Institute, La Jolla, California 92037, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1074/jbc.M109.014316DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2719310PMC
June 2009

Beta1 integrin adhesion enhances IL-6-mediated STAT3 signaling in myeloma cells: implications for microenvironment influence on tumor survival and proliferation.

Cancer Res 2009 Feb 20;69(3):1009-15. Epub 2009 Jan 20.

Experimental Therapeutics and Oncologic Sciences Program, H Lee Moffitt Cancer Center and Research Institute, Tampa, Florida 33612, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-08-2419DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2680075PMC
February 2009

MicroRNA-155 is regulated by the transforming growth factor beta/Smad pathway and contributes to epithelial cell plasticity by targeting RhoA.

Mol Cell Biol 2008 Nov 15;28(22):6773-84. Epub 2008 Sep 15.

Departments of Molecular Oncology, H. Lee Moffitt Cancer Center and Research Institute, 12902 Magnolia Dr., SRB3, Tampa, FL 33612, USA.

View Article

Download full-text PDF

Source
http://mcb.asm.org/cgi/doi/10.1128/MCB.00941-08
Publisher Site
http://dx.doi.org/10.1128/MCB.00941-08DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2573297PMC
November 2008

Static adhesion of cancer cells to glass surfaces coated with glycosaminoglycans.

Colloids Surf B Biointerfaces 2008 Nov 12;67(1):140-4. Epub 2008 Aug 12.

Department of Physics, University of South Florida, Tampa, FL 33620, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.colsurfb.2008.07.019DOI Listing
November 2008

On the eve of personalized medicine in oncology.

Cancer Res 2008 Sep;68(18):7250-2

Total Cancer Care, H. Moffitt Cancer Center and Research Institute, Tampa, Florida, USA.

View Article

Download full-text PDF

Source
http://cancerres.aacrjournals.org/cgi/doi/10.1158/0008-5472.
Publisher Site
http://dx.doi.org/10.1158/0008-5472.CAN-08-1374DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2650840PMC
September 2008

HSP70 inhibition reverses cell adhesion mediated and acquired drug resistance in multiple myeloma.

Br J Haematol 2008 Aug 22;142(4):551-61. Epub 2008 May 22.

Department of Pathobiology, College of Veterinary Medicine, Tuskegee University, Tuskegee, AL 36088, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1365-2141.2008.07217.xDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4503206PMC
August 2008

A protective role for the human SMG-1 kinase against tumor necrosis factor-alpha-induced apoptosis.

J Biol Chem 2008 May 6;283(19):13174-84. Epub 2008 Mar 6.

Department of Experimental Therapeutics, H. Lee Moffitt Cancer Center & Research Institute, University of South Florida, Tampa, Florida 33612, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1074/jbc.M708008200DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2442360PMC
May 2008

The bone marrow microenvironment as a tumor sanctuary and contributor to drug resistance.

Clin Cancer Res 2008 May;14(9):2519-26

Department of Experimental Therapeutics, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida 33612, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-07-2223DOI Listing
May 2008

Inhibition of Notch signaling induces apoptosis of myeloma cells and enhances sensitivity to chemotherapy.

Blood 2008 Feb 26;111(4):2220-9. Epub 2007 Nov 26.

H. Lee Moffitt Cancer Center and Research Institute, University of South Florida, Tampa 33612, USA.

View Article

Download full-text PDF

Source
http://www.bloodjournal.org/cgi/doi/10.1182/blood-2007-07-10
Publisher Site
http://dx.doi.org/10.1182/blood-2007-07-102632DOI Listing
February 2008

Cell adhesion induces p27Kip1-associated cell-cycle arrest through down-regulation of the SCFSkp2 ubiquitin ligase pathway in mantle-cell and other non-Hodgkin B-cell lymphomas.

Blood 2007 Sep 14;110(5):1631-8. Epub 2007 May 14.

Department of Interdisciplinary Oncology and Experimental Therapeutics Program, H. Lee Moffitt Cancer Center and Research Institute at the University of South Florida, Tampa, FL 33613, USA.

View Article

Download full-text PDF

Source
http://www.bloodjournal.org/cgi/doi/10.1182/blood-2006-11-06
Publisher Site
http://dx.doi.org/10.1182/blood-2006-11-060350DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1975846PMC
September 2007

ABCG2 expression, function, and promoter methylation in human multiple myeloma.

Blood 2006 Dec 17;108(12):3881-9. Epub 2006 Aug 17.

H. Lee Moffitt Cancer Center and Research Institute, 12902 Magnolia Dr, Tampa, FL 33612, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2005-10-009084DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1895461PMC
December 2006

Tumor microenvironment and drug resistance in hematologic malignancies.

Blood Rev 2006 Nov 22;20(6):333-42. Epub 2006 Aug 22.

H. Lee Moffitt Cancer Center and Research Institute, 12902 Magnolia Drive, SBR-2, Tampa, FL 33612, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.blre.2005.08.003DOI Listing
November 2006

Cancer biomarkers--an invitation to the table.

Science 2006 May;312(5777):1165-8

H. Lee Moffitt Cancer Center, University of South Florida, Tampa, FL 33613, USA.

View Article

Download full-text PDF

Source
http://www.sciencemag.org/cgi/doi/10.1126/science.1125948
Publisher Site
http://dx.doi.org/10.1126/science.1125948DOI Listing
May 2006

Cell adhesion to fibronectin (CAM-DR) influences acquired mitoxantrone resistance in U937 cells.

Cancer Res 2006 Feb;66(4):2338-45

Department of Interdisciplinary Oncology and Experimental Therapeutics Program, H. Lee Moffitt Cancer Center and Research Institute at the University of South Florida, Tampa, Florida 33613, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-05-3256DOI Listing
February 2006

Tipifarnib and bortezomib are synergistic and overcome cell adhesion-mediated drug resistance in multiple myeloma and acute myeloid leukemia.

Clin Cancer Res 2006 Jan;12(2):591-9

Department of Interdisciplinary Oncology, Malignant Hematology, Experimental Therapeutics, and Bone Marrow Transplant Divisions, H. Lee Moffitt Cancer Center and Research Institute, University of South Florida, 12902 Magnolia Drive, Tampa, FL 33612, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-05-1792DOI Listing
January 2006

Characterization of a R115777-resistant human multiple myeloma cell line with cross-resistance to PS-341.

Clin Cancer Res 2005 Aug;11(16):6057-64

Department of Interdisciplinary Oncology, Malignant Hematology and Experimental Therapeutics Division, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL 33612-9497, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-04-2685DOI Listing
August 2005

The FA/BRCA pathway is involved in melphalan-induced DNA interstrand cross-link repair and accounts for melphalan resistance in multiple myeloma cells.

Blood 2005 Jul 31;106(2):698-705. Epub 2005 Mar 31.

Department of Interdisciplinary Oncology and Experimental Therapeutics Program, Biostatistics Core Facility, H. Lee Moffitt Cancer Center & Research Institute at University of South Florida, 12902 Magnolia Dr, Tampa, FL 33612, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2004-11-4286DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1895179PMC
July 2005

Phase I study of a novel taxane BMS-188797 in adult patients with solid malignancies.

Clin Cancer Res 2005 May;11(9):3335-41

Experimental Therapeutics and Phase I Programs, Department of Interdisciplinary Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida 33612-9497, USA.

View Article

Download full-text PDF

Source
http://clincancerres.aacrjournals.org/content/11/9/3335.full
Web Search
http://clincancerres.aacrjournals.org/cgi/doi/10.1158/1078-0
Publisher Site
http://dx.doi.org/10.1158/1078-0432.CCR-04-1494DOI Listing
May 2005

The "total cancer care" concept: linking technology and health care.

Authors:
William S Dalton

Cancer Control 2005 Apr;12(2):140-1

H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL 33612, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/107327480501200211DOI Listing
April 2005

Proteasome inhibition in hematologic malignancies: clinical update and practical applications.

Authors:
William S Dalton

Oncology (Williston Park) 2004 Dec;18(14 Suppl 11)

View Article

Download full-text PDF

Source
December 2004

Discovery, Development, and clinical applications of bortezomib.

Oncology (Williston Park) 2004 Dec;18(14 Suppl 11):4-13

Syntaxx Communications, Inc. Atlanta, Georgia 30097-5906, USA.

View Article

Download full-text PDF

Source
December 2004

The proteasome.

Authors:
William S Dalton

Semin Oncol 2004 Dec;31(6 Suppl 16):3-9; discussion 33

H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL 33612, USA.

View Article

Download full-text PDF

Source
December 2004

The cytoplasmic trafficking of DNA topoisomerase IIalpha correlates with etoposide resistance in human myeloma cells.

Exp Cell Res 2004 May;295(2):421-31

Experimental Therapeutics Program, Departments of Interdisciplinary Oncology and Biochemistry and Molecular Biology, H. Lee Moffitt Cancer Center and Research Institute, University of South Florida, Tampa, FL 33612, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.yexcr.2004.01.012DOI Listing
May 2004

Targeting the bone marrow microenvironment in hematologic malignancies.

Semin Hematol 2004 Apr;41(2 Suppl 4):1-5

H Lee Moffitt Cancer Center and Research Institute, University of South Florida, Tampa, FL 33612, USA.

View Article

Download full-text PDF

Source
April 2004

Genotypic and phenotypic comparisons of de novo and acquired melphalan resistance in an isogenic multiple myeloma cell line model.

Cancer Res 2003 Nov;63(22):7900-6

Department of Interdisciplinary Oncology, H. Lee Moffitt Cancer Center and Research Institute, at The University of South Florida, 12902 Magnolia Drive, Tampa, FL 33612, USA.

View Article

Download full-text PDF

Source
November 2003

Role of the tumor microenvironment in mediating de novo resistance to drugs and physiological mediators of cell death.

Oncogene 2003 Oct;22(47):7396-402

Clinical Investigations Program at H Lee Moffitt Cancer Center, University of South Florida, 12902 Magnolia Drive, Tampa, FL 33612, USA.

View Article

Download full-text PDF

Source
http://www.nature.com/articles/1206943
Publisher Site
http://dx.doi.org/10.1038/sj.onc.1206943DOI Listing
October 2003

Breast tissue accumulation of retinamides in a randomized short-term study of fenretinide.

Clin Cancer Res 2003 Jul;9(7):2400-5

Departments of Clinical Cancer Prevention and Biostatistics, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030, USA.

View Article

Download full-text PDF

Source
July 2003

The tumor microenvironment: focus on myeloma.

Authors:
William S Dalton

Cancer Treat Rev 2003 May;29 Suppl 1:11-9

H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL 33612, USA.

View Article

Download full-text PDF

Source
May 2003

Cell adhesion-mediated drug resistance (CAM-DR) is associated with activation of NF-kappa B (RelB/p50) in myeloma cells.

Oncogene 2003 Apr;22(16):2417-21

Department of Interdisciplinary Oncology, H Lee Moffitt Cancer Center and Research Institute, University of South Florida, Tampa, FL 33612, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/sj.onc.1206315DOI Listing
April 2003

Synopsis of a research roundtable presented on cell signaling in myeloma: regulation of growth and apoptosis--opportunities for new drug discovery.

Mol Cancer Ther 2002 Dec;1(14):1361-5

The Jerome Lipper Multiple Myeloma Center, Dana-Farber Cancer Institute, Department of Adult Oncology, Harvard Medical School, Boston, Massachusetts 02115, USA.

View Article

Download full-text PDF

Source
December 2002

Drug resistance and drug development in multiple myeloma.

Authors:
William S Dalton

Semin Oncol 2002 Dec;29(6 Suppl 17):21-5

College of Medicine, University of Arizona Health Science Center, PO Box 245017, Tucson, AZ 85724, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/sonc.2002.34073DOI Listing
December 2002

Combination therapy with AG-490 and interleukin 12 achieves greater antitumor effects than either agent alone.

Mol Cancer Ther 2002 Sep;1(11):893-9

Immunology Program, H. Lee Moffitt Cancer Center and Research Institute, 12902 Magnolia Drive, Tampa, FL 33612, USA.

View Article

Download full-text PDF

Source
September 2002

Adhesion-mediated intracellular redistribution of c-Fas-associated death domain-like IL-1-converting enzyme-like inhibitory protein-long confers resistance to CD95-induced apoptosis in hematopoietic cancer cell lines.

J Immunol 2002 Mar;168(5):2544-53

Department of Interdisciplinary Oncology, H. Lee Moffitt Cancer Center and Research Institute, University of South Florida, Tampa, FL 33612, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4049/jimmunol.168.5.2544DOI Listing
March 2002

The tumor microenvironment as a determinant of drug response and resistance.

Drug Resist Updat 1999 Oct;2(5):285-288

Department of Interdisciplinary Oncology, H. Lee Moffitt Cancer Center, University of South Florida, Tampa, Florida, USA

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1054/drup.1999.0097DOI Listing
October 1999